Treating tuberculosis and HIV infections at the same time can be a challenge for patients... Treating TB, HIV at same time found to save lives SF Gate Logo Hearst Newspapers Logo ...

Tuberculosis is a leading killer of people with HIV, and providing therapy for both illnesses simultaneously saves lives, according to new guidelines on the treatment of drug-susceptible TB.

A 2022 study suggests that 91% of people with HIV and TB will live for at least 5 months after starting treatment for TB. It also found that 88% of people will live for at least 15 months, and 85% ...

In resource-limited settings where tuberculosis is a major cause of mortality among HIV patients and where a multidrug-resistant TB epidemic is emerging, researchers are pressing for approaches to ...

Concurrent treatment of tuberculosis (TB) and HIV infection is challenging, given drug--drug interactions, overlapping toxicities, and worsening clinical symptoms due to immune reconstitution ...

Tuberculosis has become an increasing challenge to the success of antiretroviral therapy in people with HIV, specifically for patients living in areas with limited resources for treatment. “Many ...

A new study calls for urgent action to integrate anti-smoking strategies into the care of people being treated for tuberculosis and HIV. The International Union Against Tuberculosis and Lung ...

Health ministers from Swaziland and South Africa have agreed to radically change the diagnosis and treatment of the co-epidemic of TB/HIV in their countries. They made their comments at a press ...

The research team's findings, published in the journal Lancet Infectious Diseases online Aug. 16, stem from what is believed to be the largest expansion of a clinic-based community health program ...

In resource-limited settings where tuberculosis is a major cause of mortality among HIV patients and where a multidrug-resistant TB epidemic is emerging, researchers are pressing for approaches to ...

"HIV programs have no option but to address TB vigorously to save patient lives, safeguard the massive investment in HIV treatment, and to curb the global TB burden," said Diane V. Havlir, MD ...